Atea Pharmaceuticals, Inc.·4

Oct 30, 5:40 PM ET

Foster Wayne 4

4 · Atea Pharmaceuticals, Inc. · Filed Oct 30, 2020

Insider Transaction Report

Form 4
Period: 2020-10-29
Foster Wayne
EVP, Chief Accounting Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-10-29+40,00040,000 total
    Exercise: $24.00Exp: 2030-10-28Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in 48 equal monthy installments following October 29, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION